These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Psoriasis: the visible killer. Torres T; Bettencourt N Rev Port Cardiol; 2014 Feb; 33(2):95-9. PubMed ID: 24525359 [TBL] [Abstract][Full Text] [Related]
47. Comorbidities in psoriasis patients. Kim N; Thrash B; Menter A Semin Cutan Med Surg; 2010 Mar; 29(1):10-5. PubMed ID: 20430302 [TBL] [Abstract][Full Text] [Related]
48. Activation of blood coagulation in autoimmune skin disorders. Cugno M; Tedeschi A; Crosti C; Marzano AV Expert Rev Clin Immunol; 2009 Sep; 5(5):605-13. PubMed ID: 20477646 [TBL] [Abstract][Full Text] [Related]
49. Psoriasis and the metabolic syndrome. Gottlieb AB; Dann F; Menter A J Drugs Dermatol; 2008 Jun; 7(6):563-72. PubMed ID: 18561588 [TBL] [Abstract][Full Text] [Related]
50. The heartbreak of psoriasis: a review of cardiovascular risk in patients with psoriasis. Benson MM; Frishman WH Cardiol Rev; 2015; 23(6):312-6. PubMed ID: 26440534 [TBL] [Abstract][Full Text] [Related]
51. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036 [TBL] [Abstract][Full Text] [Related]
53. Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease. Torres T; Sales R; Vasconcelos C; Martins da Silva B; Selores M J Dermatol; 2013 Nov; 40(11):923-6. PubMed ID: 24128349 [TBL] [Abstract][Full Text] [Related]
54. Cardiovascular Risk and Psoriasis: the Role of Biologic Therapy. Puig L Actas Dermosifiliogr; 2012 Dec; 103(10):853-862. PubMed ID: 22591655 [TBL] [Abstract][Full Text] [Related]
56. AJC editor's consensus: psoriasis and coronary artery disease. Friedewald VE; Cather JC; Gelfand JM; Gordon KB; Gibbons GH; Grundy SM; Jarratt MT; Krueger JG; Ridker PM; Stone N; Roberts WC Am J Cardiol; 2008 Dec; 102(12):1631-43. PubMed ID: 19064017 [No Abstract] [Full Text] [Related]
57. Future diagnosis, today's treatment - cardiomyopathy in the course of psoriasis: a case report. Pietrzak A; Brzozowska A; Lotti T; Mosiewicz J; Wysokiński A; Mieczkowska J; Hercogova J; Bartosińska J; Juszkiewicz-Borowiec M; Chodorowska G Dermatol Ther; 2013; 26(6):489-92. PubMed ID: 24552414 [TBL] [Abstract][Full Text] [Related]
58. Clinical aspects and comorbidities of psoriasis. Ayala F; Ayala F J Rheumatol Suppl; 2009 Aug; 83():19-20. PubMed ID: 19661531 [TBL] [Abstract][Full Text] [Related]
59. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Stamatelopoulos KS; Kitas GD; Papamichael CM; Chryssohoou E; Kyrkou K; Georgiopoulos G; Protogerou A; Panoulas VF; Sandoo A; Tentolouris N; Mavrikakis M; Sfikakis PP Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1702-8. PubMed ID: 19608975 [TBL] [Abstract][Full Text] [Related]
60. [Is psoriasis a dependent cardiovascular risk factor?]. Wakkee M; de Jong EM Ned Tijdschr Geneeskd; 2013; 157(11):A5417. PubMed ID: 23484510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]